Treatment Guidelines for Malaria Contd...
_ Oral quinine sulphate 600 mg/8 h for 5e7 days plus doxycycline 200 mg daily (or clindamycin 450 mg/8 h for pregnant women) for 7 days
_ Atovaquoneeproguanil (Malarone_): 4 ‘standard’ tablets daily for 3 days or
_ Co-artem ((artemetherelumefantrine_): if weight > 35 kg, 4 tablets then 4 tablets at 8, 24, 36, 48 and 60 h
_ Quinine: loading dose of 20 mg/kg quinine dihydrochloride in 5% dextrose or dextrose saline over 4 h. Followed by 10 mg/kg every 8 h for first 48 h (or until patient can swallow). Frequency of dosing should be reduced to 12 hourly if intravenous quinine continues for more than 48 h.
_ Alternative rapid quinine loading regimen (adults only) 7 mg/kg quinine dihydrochloride over 30 min using an infusion pump followed by 10 mg/kg over 4 h.
_ Parenteral quinine therapy should be continued until the patient can take oral therapy when quinine sulphate 600 mg should be given 3 times a day to complete 5e7 days of quinine in total.
_ Quinine treatment should always be accompanied by a second drug: doxycycline 200 mg (or clindamycin 450 mg 3 times a day for pregnant women, 7e13 mg/kg 3 times a day for children), given orally for total of 7 days from when the patient can swallow.
_ Artesunate regimen: appropriate for adults only on expert advice. 2.4 mg/kg given as an intravenous injection at 0, 12 and 24 h then daily thereafter. A 7-day course of doxycycline should also be given.
_ Careful management of fluid balance to optimise oxygen delivery and reduce acidosis
_ Monitoring of central venous pressure to keep right atrial pressure <>
_ Regular monitoring for hypoglycaemia
_ Consider broad spectrum antibiotics if evidence of shock or secondary bacterial infection
_ Haemofiltration for renal failure or control of acidosis or fluid/electrolyte imbalance
_ Consider medication to control seizures
_ Consideration of exchange transfusion in patients with hyperparasitaemia
Comments